7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Currently, edoxaban and ... anticoagulants (DOACs ... #Cancer #Algorithm ... Management #Hematology #Oncology
Who to test for BRCA 1/2?
Female Breast Cancer:
 • ≤ 45-50 years at diagnosis
 • Triple
in this table ... and: Ashkenazi ... factors in this table ... #indications #oncology ... #screening #diagnosis
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
†The decision to ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Management #Hematology #Oncology
Breast Cancer Mammography Screening Decision Aid - Age 50–69

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Breast Cancer Mammography ... Screening Decision ... Aid - Age 50–69 ... #PrimaryCare #Screening ... Canadian #Mortality #CTFPHC
Breast Cancer Mammography Screening Decision Aid - Age 40–49

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Breast Cancer Mammography ... Screening Decision ... Aid - Age 40–49 ... #PrimaryCare #Screening ... Canadian #Mortality #CTFPHC
Breast Cancer Mammography Screening Decision Aid - Age 70–74

Canadian Task Force on Preventive Health Care

#Diagnosis #PrimaryCare
Breast Cancer Mammography ... Screening Decision ... Aid - Age 70–74 ... #PrimaryCare #Screening ... Canadian #Mortality #CTFPHC
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... ) Cancer-treatment ... DOACs are substrates ... #Chemotherapy #Oncology ... #Interactions #Table